Double contrast-enhanced MRI of viral hepatitis-induced cirrhosis: Correlation of gross morphological signs with hepatic fibrosis

British Journal of Radiology

Volumn 83, Issue 987, 2010, Pages 212-217

  Yu, Jeong Sik ^a   Shim, J H ^a   Chung, J J ^a   Kim, J H ^a   Kim, K W ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FERUCARBOTRAN; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; EXPANDED GALLBLADDER FOSSA SIGN; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMAGE ANALYSIS; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; RIGHT POSTERIOR NOTCH SIGN;

ADULT; AGED; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; FERROSOFERRIC OXIDE; GADOLINIUM DTPA; GALLBLADDER; HEPATITIS B, CHRONIC; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77749292287     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/70974553     Document Type: Article

References (26)

1. Harbin WP, Robert NJ, Ferrucci JT Jr. Diagnosis of cirrhosis based on regional changes in hepatic morphology: a radiological and pathological analysis. Radiology 1980;135:273-83.
2. Fisher MR, Gore RM. Computed tomography in the evaluation of cirrhosis and portal hypertension. J Clin Gastroenterol 1985;7:173-81.
3. Brown JJ, Naylor MJ, Yagan N. Imaging of hepatic cirrhosis. Radiology 1997;202:1-16.
4. Lafortune M, Matricardi L, Denys A, Favret M, Dery R, Pomier-Layrargues G. Segment 4 (the quadrate lobe): a barometer of cirrhotic liver disease at US. Radiology 1998;206:157-60.
5. Giorgio A, Amoroso P, Lettieri G, Fico P, de Stefano G, Finelli L, et al. Cirrhosis: value of caudate to right lobe ratio in diagnosis with US. Radiology 1986;161:443-45.
6. Ito K, Mitchell DG, Gabata T, Hussain SM. Expanded gallbladder fossa: simple MR imaging sign of cirrhosis. Radiology 1999;211:723-6.
7. Ito K, Mitchell DG, Kim MJ, Awaya H, Koike S, Matsunaga N. Right posterior hepatic notch sign: a simple diagnostic MR finding of cirrhosis. J Magn Reson Imaging 2003;18:561-6.
8. Aguirre DA, Behling CA, Alpert E, Hassanein TK, Sirlin DB. Liver fibrosis: non-invasive diagnosis with double contrast material-enhanced MR imaging. Radiology 2006;239:425-37.
9. Frank K, Linhart P, Kortsik C, Wohlenberg H. Sonographic determination of spleen size: normal dimensions in adults with a healthy spleen [German]. Ultrashall Med 1986;7:134-7.
10. Lamb PM, Lund A, Kanagasabay RR, Martin A, Webb JA, Reznek RH. Spleen size: how well do liner ultrasound measurements correlate with three-dimensional CT volume assessment? Br J Radiol 2002;75:573-7.
11. Dodd GD III, Baron RL, Oliver JH III, Federle MP. Spectrum of imaging findings of the liver in end-stage cirrhosis. 1. Gross morphology and diffuse abnormalities. AJR Am J Roentgenol 1999;173:1031-6.
12. Spielmann AL, DeLong DM, Kliewer MA. Sonographic evaluation of spleen size in tall healthy athletes. AJR Am J Roentgenol 2005;184:45-9.
13. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factor for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993;18:47-53.
14. Chen DS. Natural history of chronic hepatitis B virus infection: new light on an old story. J Gastroenterol Hepatol 1993;8:470-5.
15. Kato Y, Nakata K, Omagari K, Furukawa R, Kusumoto Y, Mori I, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Cancer 1994;74:2234-8.
16. Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis 2000;20:17-35.
17. Ince N, Wands JR. The increasing incidence of hepatocellular carcinoma. N Engl J Med 1999;340:798-9.
18. Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986;1:523-5.
19. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500.
20. Semelka RC, Chung JJ, Hussain SM, Marcos HB, Woosley JT. Chronic hepatitis: correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience. J Magn Reson Imaging 2001;13:385-91.
21. Lucidarme O, Baleston F, Cadi M, Bellin MF, Charlotte F, Ratziu V, et al. Non-invasive detection of liver fibrosis: is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? Eur Radiol 2003;13:467-74.
22. Okazaki H, Ito K, Fujita T, Koike S, Takano K, Matsunaga N. Discrimination of alcoholic from virus-induced cirrhosis on MR imaging. AJR Am J Roentgenol 2000;175:1677-81.
23. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer P, Sobin LH. The morphology of cirrhosis. J Clin Pathol 1978;31:395-414.
24. Ganne-Carrié N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:1511-17.
25. Rosenthal SJ, Hannisson LA, Baxter KG, Wetxel LH, Cox GG, Batnitzky S. Doppler US of helical flow in the portal vein. RadioGraphics 1995;15:1103-15.
26. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C: the OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Lancet 1997;349:825-32.